{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:41:24Z","timestamp":1760298084779},"reference-count":32,"publisher":"Japanese Pharmacological Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharmacol Sci"],"published-print":{"date-parts":[[2009]]},"DOI":"10.1254\/jphs.08283fp","type":"journal-article","created":{"date-parts":[[2009,5,15]],"date-time":"2009-05-15T05:56:43Z","timestamp":1242367003000},"page":"47-54","source":"Crossref","is-referenced-by-count":13,"title":["Amelioration of Renal Ischemia\u2013Reperfusion Injury by Inhibition of IL-6 Production in the Poloxamer 407\u2013Induced Mouse Model of Hyperlipidemia"],"prefix":"10.1254","volume":"110","author":[{"given":"Satoru","family":"Sharyo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyoshi","family":"Kumagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Yokota-Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuaki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"332","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Waikar SS, Curhan GC, Wald R, McCarthy EP, Chertow GM. Declining mortality in patients with acute renal failure, 1988 to 2002. J Am Soc Nephrol. 2006;17:1143–1150.","DOI":"10.1681\/ASN.2005091017"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006010017"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2006.02.010"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Patel NS, Chatterjee PK, Di Paola R, Mazzon E, Britti D, De Sarro A, et al. Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia\/reperfusion. J Pharmacol Exp Ther. 2005;312:1170–1178.","DOI":"10.1124\/jpet.104.078659"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Kielar ML, John R, Bennett M, Richardson JA, Shelton JM, Chen L, et al. Maladaptive role of IL-6 in ischemic acute renal failure. J Am Soc Nephrol. 2005;16:3315–3325.","DOI":"10.1681\/ASN.2003090757"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–1847.","DOI":"10.1161\/01.CIR.97.18.1837"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Dalrymple LS, Kaysen GA. The Effect of Lipoproteins on the Development and Progression of Renal Disease. Am J Nephrol. 2008;28:723–731.","DOI":"10.1159\/000127980"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Kwan BC, Kronenberg F, Beddhu S, Cheung AK. Lipoprotein metabolism and lipid management in chronic kidney disease. J Am Soc Nephrol. 2007;18:1246–1261.","DOI":"10.1681\/ASN.2006091006"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Nitzan M. Abnormalities of carbohydrate and lipid metabolism in experimentally induced acute uremia. Nutr Metab. 1973;15:187–191.","DOI":"10.1159\/000175439"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Buzello M, Haas CS, Hauptmann F, Gross ML, Faulhaber J, Schultze-Mosgau S, et al. No aggravation of renal injury in apolipoprotein E knockout mice (ApoE−\/<\/sup>−<\/sup>) after subtotal nephrectomy. Nephrol Dial Transplant. 2004;19:566–573.","DOI":"10.1093\/ndt\/gfg578"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Campos SB, Ori M, Dórea EL, Seguro AC. Protective effect of L-arginine on hypercholesterolemia-enhanced renal ischemic injury. Atherosclerosis. 1999;143:327–334.","DOI":"10.1016\/S0021-9150(98)00319-0"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2008.210"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199705000-00003"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199912000-00010"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1038\/ng814"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Fujimoto K, Koishi R, Shimizugawa T, Ando Y. Angptl3-null mice show low plasma lipid concentrations by enhanced lipoprotein lipase activity. Exp Anim. 2006;55:27–34.","DOI":"10.1538\/expanim.55.27"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Thurman JM, Ljubanovic D, Edelstein CL, Gilkeson GS, Holers VM. Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice. J Immunol. 2003;170:1517–1523.","DOI":"10.4049\/jimmunol.170.3.1517"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Zhang Q, Zeng X, Guo J, Wang X. Oxidant stress mechanism of homocysteine potentiating Con A-induced proliferation in murine splenic T lymphocytes. Cardiovasc Res. 2002;53:1035–1042.","DOI":"10.1016\/S0008-6363(01)00541-7"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Kishimoto T, Akira S, Narazaki M, Taga T. Interleukin-6 family of cytokines and gp130. Blood. 1995;86:1243–1254.","DOI":"10.1182\/blood.V86.4.1243.bloodjournal8641243"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Lai LW, Yong KC, Igarashi S, Lien YH. A sphingosine-1-phosphate type 1 receptor agonist inhibits the early T-cell transient following renal ischemia-reperfusion injury. Kidney Int. 2007;71:1223–1231.","DOI":"10.1038\/sj.ki.5002203"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Rabb H, Daniels F, O’Donnell M, Haq M, Saba SR, Keane W, et al. Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice. Am J Physiol Renal Physiol. 2000;279:F525–F531.","DOI":"10.1152\/ajprenal.2000.279.3.F525"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Burne MJ, Daniels F, El Ghandour A, Mauiyyedi S, Colvin RB, O’Donnell MP, et al. Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure. J Clin Invest. 2001;108:1283–1290.","DOI":"10.1172\/JCI12080"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature. 1990;343:425–430.","DOI":"10.1038\/343425a0"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Laufs U, Liao JK. Direct vascular effects of HMG-CoA reductase inhibitors. Trends Cardiovasc Med. 2000;10:143–148.","DOI":"10.1016\/S1050-1738(00)00044-X"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1549407"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Hillyard DZ, Jardine AG, McDonald KJ, Cameron AJ. Fluvastatin inhibits raft dependent Fcgamma receptor signalling in human monocytes. Atherosclerosis. 2004;172:219–228.","DOI":"10.1016\/j.atherosclerosis.2003.11.004"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Xue X, Lai KT, Huang JF, Gu Y, Karlsson L, Fourie A. Anti-inflammatory activity in vitro and in vivo of the protein farnesyltransferase inhibitor tipifarnib. J Pharmacol Exp Ther. 2006;317:53–60.","DOI":"10.1124\/jpet.105.095976"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.1996.v24.pm0008707269"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Moghadasian MH, McManus BM, Nguyen LB, Shefer S, Nadji M, Godin DV, et al. Pathophysiology of apolipoprotein E deficiency in mice: relevance to apo E-related disorders in humans. FASEB J. 2001;15:2623–2630.","DOI":"10.1096\/fj.01-0463com"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Scheuer H, Gwinner W, Hohbach J, Gröne EF, Brandes RP, Malle E, et al. Oxidant stress in hyperlipidemia-induced renal damage. Am J Physiol. 2000;278:F63–F74.","DOI":"10.1152\/ajprenal.2000.278.1.F63"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Girod WG, Jones SP, Sieber N, Aw TY, Lefer DJ. Effects of hypercholesterolemia on myocardial ischemia-reperfusion injury in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol. 1999;19:2776–2781.","DOI":"10.1161\/01.ATV.19.11.2776"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Jones SP, Girod WG, Marotti KR, Aw TY, Lefer DJ. Acute exposure to a high cholesterol diet attenuates myocardial ischemia-reperfusion injury in cholesteryl ester transfer protein mice. Coron Artery Dis. 2001;12:37–44.","DOI":"10.1097\/00019501-200102000-00006"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T15:05:41Z","timestamp":1621436741000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jphs\/110\/1\/110_08283FP\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1254\/jphs.08283fp","relation":{},"ISSN":["1347-8613","1347-8648"],"issn-type":[{"value":"1347-8613","type":"print"},{"value":"1347-8648","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009]]}}}